nach oben

Journal of Gastrointestinal Cancer

Erschienen in:

21.09.2019 | Case Report

Tumor Lysis Syndrome After Laparoscopic Microwave Ablation of Colorectal Liver Metastases

verfasst von: Adam C. Sheka, Ariella Altman, Alessandro Gasparetto, Benjamin Spilseth, Sydne Muratore, Eric H. Jensen

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Excerpt

Colorectal cancer is the third most common malignancy in the USA and has the second highest mortality rate after lung cancer [1, 2]. Liver metastases affect up to 60% of patients diagnosed with colorectal cancer. Adequate control of liver metastases is challenging, as only 25% of patients have surgically resectable disease at presentation. Ablative therapies in conjunction with systemic chemotherapy have been shown to improve survival in patients with unresectable colorectal liver metastases [3]. In-hospital and early post-procedural complications after ablation of metastatic liver tumors are poorly studied but may be higher than initially reported [4, 5]. …

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. https://doi.org/10.3322/caac.21387.CrossRef

Singh SD, Henley SJ, Ryerson AB. Surveillance for cancer incidence and mortality – United States, 2013. MMWR Surveill Summ. 2017;66(4):1–36. https://doi.org/10.15585/mmwr.ss6604a1.CrossRefPubMedPubMedCentral

Ruers T, Van Coevorden F, Punt CJ, Pierie JE, Borel-Rinkes I, Ledermann JA, et al. Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial. J Natl Cancer Inst. 2017;109(9):1–10. https://doi.org/10.1093/jnci/djx015.CrossRef

Tuttle RM, Fox JP, Ouellette JR, Hellan M. Hospital-based, acute care encounters after radiofrequency ablation of hepatic tumors. HPB (Oxford). 2014;16(9):845–51. https://doi.org/10.1111/hpb.12220.CrossRef

Park JG, Park SY, Tak WY, Kweon YO, Jang SY, Lee YR, et al. Early complications after percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1,843 ablations in 1,211 patients in a single centre: experience over 10 years. Clin Radiol. 2017;72(8):692.e9–e15. https://doi.org/10.1016/j.crad.20147.03.001.CrossRef

Howard SC, Jones DP, Pui C. The tumor lysis syndrome. N Engl J Med. 2011;364(19):1844–54. https://doi.org/10.1056/NEJMra0904569.

Mirrakhimov AE, Ali AM, Kahn M, Barbaryan A. Tumor lysis syndrome in solid tumors: an up to date review of the literature. Rare Tumors. 2014;6(2):5389–96. https://doi.org/10.4081/rt.2014.5389.CrossRefPubMedPubMedCentral

Baeksgaard L, Sørensen JB. Acute tumor lysis syndrome in solid tumors—a case report and review of the literature. Cancer Chemother Pharmacol. 2003;51(3):187–92. https://doi.org/10.1007/s00280-002-0556-x.CrossRefPubMed

Drakos P, Bar-Ziv J, Catane R. Tumor lysis syndrome in nonhematologic malignancies: report of a case and review of the literature. Am J Clin Oncol. 1994;17(6):502–5.CrossRef

10.

Kalemkerian GP, Darwish B, Varterasian ML. Tumor lysis syndrome in small cell carcinoma and other solid tumors. Am J Med. 1997;103(5):363–7.CrossRef

11.

Gemici C (2006) Tumour lysis syndrome in solid tumors. Clin Oncol (R Coll Radiol) 18(10):773–780.

12.

Lin H, Chang W, Wang H, Chen M, Shih S. Transarterial chemoembolization-induced tumor lysis syndrome: different results in the same hepatocellular carcinoma patient. Int J Gerontol. 2014;8(3):171–4. https://doi.org/10.1016/j.ijge.2014.03.005.CrossRef

13.

Shiba H, Ishida Y, Wakiyama S, Sakamoto T, Misawa T, Yanaga K. Acute tumor lysis syndrome after transarterial chemoembolization for hepatocellular carcinoma. Cancer Sci. 2008;99(10):2104–5. https://doi.org/10.1111/j.1349-7006.2008.00958.x.CrossRefPubMed

14.

Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg. 1999;23(2):109–13.CrossRef

15.

Lehner SG, Gould JE, Saad WE, Brown DB. Tumor lysis syndrome after radiofrequency ablation of hepatocellular carcinoma. AJR Am J Roentgenol. 2005;185:1307–9. https://doi.org/10.2214/AJR.04.1265.CrossRefPubMed

16.

Pearson AS, Izzo F, Fleming D, Ellis LM, Delrio P, Roh MS, et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg. 1999;178(6):592–9.CrossRef

17.

Barry BD, Kell MR, Redmond HP. Tumor lysis syndrome following endoscopic radiofrequency interstitial thermal ablation of colorectal liver metastases. Surg Endosc. 2002;16(7):1109. https://doi.org/10.1007/s00464-001-4246-2.CrossRefPubMed

18.

Hentrich M, Schiel X, Scheidt B, Reitmeier M, Hoffman U, Lutz L. Fatal tumor lysis syndrome after irinotecan/5-FU/folinic acid/bevacizumab-containing therapy in a patient heavily pretreated for metastatic colon cancer. Acta Oncol. 2008;47(1):155–6. https://doi.org/10.1080/02841860701460533.CrossRefPubMed

19.

Boisseau M, Bugat R, Mahjoubi M. Rapid tumour lysis syndrome in a metastatic colorectal cancer increased by treatment (CPT-11). Eur J Cancer. 1996;32A(4):737–8.CrossRef

20.

Oztop I, Demirkan B, Yaren A, Tarhan O, Sengul B, Ulukus C, et al. Rapid tumor lysis syndrome in a patient with metastatic colon cancer as a complication of treatment with 5-fluorouracil/leucoverin and irinotecan. Tumori. 2004;90(5):514–6.CrossRef

21.

Krishnan G, D’Silva K, Al-Janadi A. Cetuximab-related tumor lysis syndrome in metastatic colon carcinoma. J Clin Oncol. 2008;26(14):2406–8. https://doi.org/10.1200/JCO.2007.14.7603.CrossRefPubMed

22.

Curley SA. Radiofrequency ablation of malignant liver tumors. Oncologist. 2011;6(1):14–23.CrossRef

Titel: Tumor Lysis Syndrome After Laparoscopic Microwave Ablation of Colorectal Liver Metastases
verfasst von: Adam C. Sheka
Ariella Altman
Alessandro Gasparetto
Benjamin Spilseth
Sydne Muratore
Eric H. Jensen
Publikationsdatum: 21.09.2019
Verlag: Springer US
Erschienen in: Journal of Gastrointestinal Cancer / Ausgabe 2/2020
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI: https://doi.org/10.1007/s12029-019-00308-8

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Springer Medizin

Tumor Lysis Syndrome After Laparoscopic Microwave Ablation of Colorectal Liver Metastases

Excerpt

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2020

Schistosomiasis Misleading Gastric Cancer Treatment

Biliary Fibrosis and Portal Hypertension as a Rare Cause of Cholangiocarcinoma

Surgical Resection of Multiple Small Bowel Neuroendocrine Tumours Using Intraoperative Fluorescence Angiography with Indocyanine Green Dye

DCLK1 as a Promising Marker for Radioresistance in Colorectal Cancer

Monomorphic Epitheliotropic Intestinal T Cell Lymphoma of the Appendix: a Case Report and Review of Literature

Primary Tumor Location Is a Predictor of Poor Prognosis in Patients with Locally Advanced Esophagogastric Cancer Treated with Perioperative Chemotherapy

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Onkologie